Dihydroberberine
Dihydroberberine has anti-atherosclerotic anti-inflammatory hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.
Product Specifications
CAS Number
483-15-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
337.4
Molecular Formula
C20H19NO4
Notes
Research use only, not for human use.
Receptor
HERG| HSP90
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040263-APC 200 µL
POLR2J, CT (POLR2J, POLR2J1, DNA-directed RNA polymerase II subunit RPB11-a, DNA-directed RNA polymerase II subunit J-1, RNA polymerase II 13.3kD subunit) (APC) discontinued
Sign In for Pricing
View Details 
ELI-08724h 96 Tests
Human Metabotropic glutamate receptor 6, GRM6 ELISA KIT
Sign In for Pricing
View Details C5900-07-01 5 L
CMRL1066 w/L-Glutamine, w/o Choline Chloride, Sodium Acetate (Powder)
Sign In for Pricing
View Details C5900-07-02 10 L
CMRL1066 w/L-Glutamine, w/o Choline Chloride, Sodium Acetate (Powder)
Sign In for Pricing
View Details